Abstract
The revascularization procedures become more and more popular to treat coronary artery disease, in many countries. Some patients are free of angina after revascularization, without any documented re-stenosis present with recurrent angina symptoms after a period of time. The aim of this work was to assess the efficacy of trimetazidine in the subpopulation of patients with a history of PTCA or CABG, who were included in the TRIMPOL II study. A subgroup of 94 patients was retrospectively analysed from the TRIMPOL II study, a multicentre, double-blind randomised placebo-controlled trial in 426 patients with stable effort angina. These patients have a history of revascularization for coronary artery disease, and they are still symptomatic after 6 months despite a treatment with metoprolol (50 mg twice daily). They were randomly allocated to receive either trimetazidine (20 mg 3 times daily) or placebo for 12 weeks, on top of the beta-blocker. Exercise test parameters, clinical efficacy and safety were assessed. Results were analysed using the Student test, the Mann-Whitney test or the Shapiro-Wilk test. Compared to placebo, the 12-week treatment with trimetazidine significantly improved: time to 1 mm ST segment depression (385.1 s +...Continue Reading
References
Jan 2, 1992·The New England Journal of Medicine·A F ParisiP Hartigan
Jul 1, 1992·Circulation·UNKNOWN VA Coronary Artery Bypass Surgery Cooperative Study Group
Aug 1, 1990·Cardiovascular Drugs and Therapy·S Dalla-VoltaA Desideri
Nov 1, 1990·Circulation·E L AldermanT L Robertson
Aug 27, 1994·Lancet·S YusufR Norris
Oct 20, 1994·The New England Journal of Medicine·S B KingX Q Zhao
Mar 1, 1997·European Heart Journal
Dec 24, 1997·Heart·S C Manchanda, S Krishnaswami
Sep 16, 1998·The American Journal of Cardiology·A Desideri, L Celegon
Nov 10, 1998·Lancet·R A HendersonJ R Hampton
Jun 11, 1999·Journal of the American College of Cardiology·R J GibbonsS C Smith
Mar 17, 2000·Circulation Research·P F KantorG D Lopaschuk
Jun 22, 2000·Circulation·F FeitK M Detre
Apr 12, 2001·The New England Journal of Medicine·P W SerruysUNKNOWN Arterial Revascularization Therapies Study Group
May 5, 2001·Expert Opinion on Pharmacotherapy·H R Cross
Dec 1, 2001·European Heart Journal·H SzwedM Winter
Jan 25, 2003·Coronary Artery Disease·Werner W KleinLuigi Tavazzi
Mar 26, 2003·Coronary Artery Disease·Mario Marzilli, Werner W Klein
Apr 2, 2003·Fundamental & Clinical Pharmacology·William C Stanley, Mario Marzilli
Citations
Dec 25, 2007·Cardiovascular Drugs and Therapy·Fanny VaillantQuadiri Timour
Jun 23, 2007·American Heart Journal·Letícia Weiss RibeiroCarísi Anne Polanczyk
Mar 10, 2006·Current Cardiology Reports·Sonal Jani, Steven R Bergmann
Jan 15, 2014·Journal of Cardiac Failure·José Luis WinterSergio Lavandero
Jan 18, 2008·International Journal of Cardiology·Giuseppe MarazziGiuseppe M C Rosano
May 20, 2008·Cardiovascular Therapeutics·A Onay-Besikci, S A Ozkan
Aug 26, 2006·The American Journal of Cardiology·Nicolas Danchin
Aug 26, 2006·The American Journal of Cardiology·Vicente Bertomeu-GonzalezJuan Carlos Kaski
Jun 1, 2012·European Heart Journal. Acute Cardiovascular Care·Paolo IzzoNatale Daniele Brunetti
Aug 22, 2013·Korean Circulation Journal·Selami DemirelliZiya Simşek
Nov 27, 2007·Expert Review of Cardiovascular Therapy·Wei Wang, Gary D Lopaschuk
Jan 7, 2014·American Journal of Therapeutics·Csaba A Dézsi
Apr 11, 2014·Angiology·Konstantinos TsioufisAthanasios Manolis
Nov 29, 2020·Cardiology and Therapy·Maria Glezer, UNKNOWN CHOICE-2 study investigators
Mar 15, 2021·Indian Heart Journal·Jamshed Dalal, Aditya Kapoor
Feb 17, 2019·American Heart Journal·Roberto FerrariNicolas Danchin